Leef is positioning itself as the “Intel Inside” of cannabis concentrates—pairing rare, permitted low-cost California biomass with industrial extraction scale to supply the fastest-growing product categories in California and New York.
Overview
Leef Brands (LEEF.CN) has transitioned from a marketing-heavy CPG cannabis company into a vertically integrated, high-throughput extraction and manufacturing supplier focused on California and New York. Its core premise is to be the “Intel Inside” of cannabis: producing the concentrates that power the industry’s fastest-growing and highest-profit categories (vapes, edibles, infused pre-rolls) rather than competing for consumer brand loyalty. FY2025 revenue rose to **$34.8M (+22% YoY)**, with **~90%** driven by B2B bulk concentrate sales (about **$31.3M**) to major brands and MSOs (e.g., Wyld, Kiva, Heavy Hitters). The key differentiator is vertical biomass supply via the **1,900-acre Salisbury Canyon Ranch** in Santa Barbara County, cutting biomass input costs to **~$8/lb** (vs **$20–$50/lb** market) and supporting sharp margin expansion (Q4 FY2025 **45.5%** gross margin exit rate). Operationally, the company spans ethanol, hydrocarbon, and solventless extraction, enabling both mass-market distillate and premium live resin/rosin. In New York, the Hobart facility entered a market with significant scarcity of compliant concentrate supply, and initial production was reportedly fully committed—suggesting strong early demand and potential pricing power. The investment case is a margin-and-cash-flow inflection driven by SCR scale-up and NY utilization, tempered by execution risk (harvest cycles), regulatory overhang (Santa Barbara rules; federal illegality/280E), thin liquidity, and leverage.